Recent content from Burl Gilyard
Abbott's Similac recall complicated an already tight supply of the crucial infant nutrition.
The company and government examined three instances when HeartWare users experienced pump thrombosis, a severe malfunction.
Company posted first-quarter profit of $97 million.
The medtech and diagnostics company with a sizable Minnesota presence saw profits rise 36.5%, but a Similac infant formula recall dampened its outlook.
Medtronic, Medical Alley and others in innovation-driven industries object to a tax law they say hinders life-changing developments.
The med-tech connection between Minnesota and Australia keeps expanding, building on a history of shared specialties.
Most of Minnesota's investment funds are headquartered in the Twin Cities, but Rochester group seeds companies largely in the southeast corner of the state.
HeartWare was pulled from the market last year as growing clinical research suggested higher rate of stroke and death among patients with device.
The Arden Hills company has landed $13 million in financing.
The New Brighton medical technology firm, reliant chiefly on a single product over the last three decades, plans eight new ones in coming years.
Que Dallara joins the company from Honeywell. The med-tech giant also appoints two new unit presidents.
ANI Pharmaceuticals, a publicly traded company in Baudette, reported lackluster earnings Tuesday, but hopes new anti-inflammation medication will boost growth.
EyeBox secured its latest FDA clearance in January for the small machine that tracks eye movement to detect a possible brain injury.
Minneapolis-based company has partnered with American Cancer Society for six-year research project.
Big increases on meat and gas feel bad now, but hikes in costs of services have been far greater over time.
Buyer Altaris Capital Partners is majority owner of Minnetronix Medical.
An outreach program to detect colorectal cancer, which affects Black people disproportionately, came as Medtronic disclosed mixed financial results.
By every measure, Manny Villafana has had a successful career, but the serial entrepreneur is not done yet.
The company announced fourth-quarter results and outlined expansion details for its manufacturing facility in the Twin Cities suburb.
Sales of pandemic-related products accounted for 20% of its fourth-quarter revenue.
The medical device company, with its operational headquarters in Fridley, said it is working to comply with the FDA findings.
Manufacturing and supply chain constraints delayed shipments to new European customers, but the company says demand remains high.
Affera makes cardiac mapping and navigation systems and catheter-based cardiac ablation technologies.
The development organization named a finalist in federal competition.
Golden Valley-based Inspire Medical Systems saw demand soar for its implantable treatment in 2021.
New owner looks to grow state's small number of medical cannabis patients
The northern suburb is becoming home to more of the region's medical manufacturers.
Adjacent One Discovery Square is completely full
Many companies stumbled after going public, floundering under investor scrutiny.
Federal regulators raised concerns over how the business division handled complaints, assessed product risks and dealt with recalls.
The value of Fresh Vine Wine, the eighth Minnesota company with an IPO this year, dropped 30% in its first day of trading.
Lemon Medical in Hammelburg, Germany, is the third acquisition in three years for MGC Diagnostics.
Company expects to take $2.5 million charge
Profits topped expectations and emerging markets saw solid growth despite COVID-19 continuing to quell U.S. growth.
Generic drugmaker paying $197 million for New Jersey-based Novitium Pharma, the largest-ever deal in the publicly traded company's history
Remote endoscopy technology signals a new frontier for Minnesota medtech giant
The Green Bay Packers kicked off a common "stock" sale on Tuesday. But the team, selling 300,000 shares at $300 per share, is quick to note: It's not really stock.
The prolonged pandemic continues to overburden medical facilities, limiting growth for the medical device company.
Many of its downtown Minneapolis workers will be offered a chance to move to the combined company's new headquarters in Kansas City.